Literature DB >> 27712792

Lymphomas-Part 1.

Lara A Brandão1, Mauricio Castillo2.   

Abstract

Primary central nervous system lymphomas are aggressive, high-cell-density tumors. There is recent increase in their incidence in immunocompetent patients. Knowledge of imaging findings on computed tomography and conventional MR imaging is important to suggest the diagnosis. Moreover, information obtained from advanced MR imaging techniques, such as diffusion-weighted imaging, diffusion tensor imaging, MR spectroscopy, perfusion-weighted imaging, and dynamic contrast-enhanced studies, increases diagnostic confidence and helps distinguish them from other aggressive intracranial tumors. This article discusses typical imaging findings of primary and secondary central nervous system lymphomas on computed tomography and conventional MR imaging, advanced MR imaging techniques, and changes related to steroid therapy.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CNS lymphoma; Diffusion tensor imaging; Diffusion-weighted imaging; Dynamic contrast enhanced MR imaging; Imaging findings in lymphoma; MR spectroscopy; Perfusion-weighted imaging; Posttreatment evaluation

Mesh:

Year:  2016        PMID: 27712792     DOI: 10.1016/j.nic.2016.06.004

Source DB:  PubMed          Journal:  Neuroimaging Clin N Am        ISSN: 1052-5149            Impact factor:   2.264


  3 in total

Review 1.  Clinical Applications of Magnetic Resonance Spectroscopy in Brain Tumors: From Diagnosis to Treatment.

Authors:  Brent D Weinberg; Manohar Kuruva; Hyunsuk Shim; Mark E Mullins
Journal:  Radiol Clin North Am       Date:  2021-03-23       Impact factor: 2.303

2.  Conventional MR and DW imaging findings of cerebellar primary CNS lymphoma: comparison with high-grade glioma.

Authors:  Ye-Xin He; Chong-Xiao Qu; Yuan-Yan He; Jia Shao; Qiang Gao
Journal:  Sci Rep       Date:  2020-06-19       Impact factor: 4.379

3.  Primary central nervous system small lymphocytic lymphoma in the bilateral ventricles: two case reports.

Authors:  Rongjing Guo; Xiaolong Zhang; Chunxiao Niu; Yibin Xi; Hong Yin; Hong Lin; Ting Chang
Journal:  BMC Neurol       Date:  2019-08-19       Impact factor: 2.474

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.